Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05828511
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-04-12
Brief Title:
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals